Biocryst Pharmaceuticals reported $1.86M in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
DBV Technologies DBVT:US USD 10.71M 1000
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Chugai Pharma 4519:JP JPY 73.2B 0
Daiichi Sankyo 4568:JP JPY 50B 0
Glaxosmithkline GSK:US GBP 1.35B 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Intra Cellular Therapies ITCI:US USD 9K 0
IONIS PHARMACEUT IONS:US USD 142K 0
Karyopharm Therapeutics KPTI:US USD 8K 0
Mirati Therapeutics MRTX:US USD 58K 2K
Neurocrine Biosciences NBIX:US USD 100K 0
Novavax NVAX:US USD 792K 4K
Ptc Therapeutics PTCT:US USD 71K 0
Roche Holding ROG:VX 107M 53M
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
YTE INCY:US USD 222K 0